Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Small peptide IL-1beta receptor antagonist from Serodus delays diabetes onset in vivo

Feb. 11, 2016

AbbVie reports topline results from phase III elagolix trial in endometriosis

Feb. 11, 2016

FDA clears Sangamo's IND for SB-318

Feb. 9, 2016

Lifesci Pharmaceuticals describes kallikrein inhibitors

Feb. 9, 2016

Celgene reports GLP-1 receptor ligands

Feb. 9, 2016

Piramal Enterprises discloses GPR120 agonists

Feb. 9, 2016

Versartis reports results from extension study of somavaratan in children with GHD

Feb. 3, 2016

Repurposing RXR agonist HX-630: Possible new treatment for Cushing's disease?

Feb. 3, 2016

Transition Therapeutics reports phase II results for oxyntomodulin analogue TT-401

Feb. 2, 2016

AbbVie starts enrollment in phase III clinical program for elagolix in uterine fibroids

Feb. 1, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...